Unclaimed Scholar Profile
Are you Shabir Ahmed Madhi? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of the WitwatersrandASIDASID-2295-1137-8242 orcid.org/0000-0002-7629-0636
Shabir Ahmed Madhi
University of the Witwatersrand•South Africa
Faculty researcher at University of the Witwatersrand, specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities]
#Pneumonia and Respiratory Infections#Bacterial Infections and Vaccines#Respiratory viral infections research
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 63,251 | 13,759 |
| h-index | 105 | 74 |
| i10-index | 585 | 351 |
Annual Citation Growth
Verified Citations / Year0
20201.4k
2021+40%1.9k
2022+29%2.5k
2023+33%3.3k
2024-8%3.0k
2025-45%1.7k
2026Scholarship Distribution & Proportions948 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (51,866) • 18% Global Research Impact (11,385)
948 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
1Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (948)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
Published in The Lancet•2022
DOI: 10.1016/s0140-6736(22)00478-0 Verified Peer-Reviewed
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants
Published in New England Journal of Medicine•2008
DOI: 10.1056/nejmoa0800971 Verified Peer-Reviewed
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Published in New England Journal of Medicine•2021
DOI: 10.1056/nejmoa2102214 Verified Peer-Reviewed
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
Published in The Lancet•2021
DOI: 10.1016/s0140-6736(21)00432-3 Verified Peer-Reviewed
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
Published in New England Journal of Medicine•2022
DOI: 10.1056/nejmoa2110275 Verified Peer-Reviewed
Showing 1 – 5 of 948 publications
1 / 190